Efficacy of Atazanavir/Ritonavir Monotherapy as Maintenance in Patients With Viral Suppression
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
The study will assess whether Atazanavir/ritonavir monotherapy provides a non-inferior
proportion of virological efficacy with respect to ATV/RTV + 2 NRTIs in patients with stable
suppressed viremia and no prior virologic failures.